CSF3R and atypical chronic myeloid leukemia, BCR-ABL1 negative: Meggendorfer et al. found that only six of 14 CNL patients (43%) harbored CSF3R mutations and additionally identified CSF3R mutations in two of 58 (3.4%) aCML patients and two of 146 (1.4%) CMML patients19.